secwatch.observer — SEC 8-K summary
======================================

Issuer:     CHEMED CORP (CHE)
CIK:        0000019584
Form:       8-K
Filed at:   2022-10-31T23:59:59+00:00
Accession:  0001562762-22-000404
Event type: earnings
Sentiment:  neutral
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Chemed Q3 revenue down 2.3% to $526M; raises 2022 adjusted EPS guidance to $19.60-$19.70
--------------------------------------------------------------------------------

- GAAP diluted EPS of $3.78; adjusted diluted EPS of $4.74, down 6.3% YoY.
- VITAS net revenue fell 6.6% to $297M; ADC down 4.4% to 17,242; admissions down 16.6%.
- Roto-Rooter revenue rose 3.9% to $230M; adjusted EBITDA margin improved 50bps to 30.2%.
- Company repurchased 50,000 shares for $23.9M at avg cost $477.68; $101M authorization remaining.
- 2022 adjusted EPS guidance raised to $19.60-$19.70 from $19.30-$19.50; VITAS revenue forecast down 4.5%-5%.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/19584/000156276222000404/0001562762-22-000404-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/19584/000156276222000404/che-20221031x8k.htm
  HTML page:      https://secwatch.observer/filing/0001562762-22-000404

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer